Jale Dolucan

Jale Dolucan is an experienced clinical quality lead and scientist with a strong background in GCLP compliance and bioanalysis. Currently employed at Adaptimmune since September 2022, Jale previously held senior roles at Achilles Therapeutics plc and Freeline, where responsibilities included leading immune monitoring processes, supervising GCLP lab setups, and implementing essential quality control processes. Jale has extensive experience in training, recruitment, and process improvement within laboratory environments, with a solid foundation in various laboratory techniques and project management. Jale holds a Master's degree in Clinical Drug Development from QMUL and a Bachelor's degree in Physiology and Pharmacology from UCL.